|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2016
vol. 118 abstract:
Original paper
Central corneal thickness and intraocular pressure before the intravitreal administration of ranibizumab and in the early period following the injection
Dorota Białas-Niedziela
1
,
Andrzej Olechowski
1
,
Joanna Ciszewska
1
,
Iwona Świtka-Więcławska
1
,
Dariusz Kęcik
1
Online publish date: 2017/11/29
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
The aim of the study was to determine the differences in the central corneal thickness and intraocular pressure measured before intravitreal administration of ranibizumab and at 30 to 60 minutes after the injection. The intraocular pressure was analysed as a stand-alone parametre and in correlation with the central corneal thickness. 72 patients (144 eyes) were enrolled. The treated eyes were compared to the fellow, non-treated eyes. The mean central corneal thickness in a treated eye was 558 µm and 596 µm at baseline (before the injection) and after the injection, respectively (p< 0.05). The mean intraocular pressure not correlated to the central corneal thickness in a treated eye 15.29 mmHg and 16.83 mmHg at baseline and post-injection, respectively (p< 0.05). When assessed in correlation with the central corneal thickness, the intraocular pressure did not increase post-injection in the treated eyes.
keywords:
corneal thickness (CCT), intraocular pressure (IOP), corneal edema, intravitreal injection, ranibizumab |
|
POLSKI
